Identification of Diverse OXA-40 Group Carbapenemases, Including a Novel Variant, OXA-160, fromAcinetobacter baumanniiin Pennsylvania
- 1 January 2011
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (1), 429-432
- https://doi.org/10.1128/aac.01155-10
Abstract
Three Acinetobacter baumannii isolates that possess OXA-40 group carbapenemase genes were identified. They belonged to novel sequence types (ST122, ST123, and ST124) and harbored bla OXA-160, bla OXA-72, and bla OXA-40, respectively. OXA-160 is a novel variant of OXA-40 with a P227S substitution. An isogenic Escherichia coli clone producing OXA-160 was more susceptible to carbapenems than a clone producing OXA-40. The genetic environment of bla OXA-160 and bla OXA-40 beyond the putative XerC/XerD recombination sites was distinct from the scaffold reported previously.Keywords
This publication has 16 references indexed in Scilit:
- Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing schemeClinical Microbiology & Infection, 2011
- OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial OutbreakAntimicrobial Agents and Chemotherapy, 2010
- Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2009
- Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemaseJournal of Antimicrobial Chemotherapy, 2009
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in PennsylvaniaAntimicrobial Agents and Chemotherapy, 2008
- Emergence and Clonal Dissemination of OXA-24- and OXA-58-Producing Acinetobacter baumannii Strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance ProgramJournal of Clinical Microbiology, 2008
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysisProceedings of the National Academy of Sciences, 2007
- Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40Antimicrobial Agents and Chemotherapy, 2006